LeMaitre attracts corporate heavyweight to board, audit group
This article was originally published in Clinica
Executive Summary
LeMaitre Vascular (Burlington, Massachusetts), a developer and manufacturer of devices for the treatment of peripheral vascular disease, has appointed John O’Connor to its board of directors; he will also serve as chair of the company’s audit committee. Mr O’Connor retired in 2006, before which he was vice-chairman of services for PricewaterhouseCoopers, where he was a partner for 24 years. The appointment should enable LeMaitre to "regain compliance with the Marketplace Rules of the Nasdaq Stock Market, which require that a majority of the company’s board of directors be independent and that the company’s audit committee be composed of three or more independent directors”. Mr O’Connor’s “strategic acumen” will be an “ideal complement” to those of other board members, said chairman and CEO George LeMaitre.